MedTrace Logo

Epidemiology and Outcomes of Gram Negative Urosepsis

NCT02380170 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 600

Last updated 2020-08-07

No results posted yet for this study

Summary

The study aims to get an insight on the causative bacteria of sepsis derived from the urinary tract. Furthermore, it is the intention to understand the outcomes of these patients. For this purpose a non-interventional, observational study will be conducted.

Conditions

  • Urosepsis

Sponsors & Collaborators

  • European Association of Urology Research Foundation

    lead OTHER

Principal Investigators

  • Truls Erik Bjerklund Johansen, Prof. · Oslo Univeristy, Norway

  • Florian Wagenlehner, Prof. · Giessen Univeristy, Germany

  • Zafer Tandogdu, MD · Northern Institute for Cancer Research, Newcastle University, UK

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-09-30
Primary Completion
2018-08-24
Completion
2020-05-24

Countries

  • Hungary
  • Italy
  • North Macedonia
  • Norway
  • Poland
  • Portugal
  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02380170 on ClinicalTrials.gov